Over the past 10 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 3-day program and extensive networking opportunities that CHI's IO Summit provides.
Topics: Bispecific Antibodies for Cancer Immunotherapy, Advances in CAR T Therapy, Preclinical and Translational Immuno-Oncology, Combination Immunotherapies for Cancer, Emerging Technologies for IO Targeting & Discovery, Emerging Cell-Based Immunotherapies, Immuno-Oncology Biomarkers, Overcoming Resistance to IO Therapy,